Anti-ganglioside compound for targeting cancer and generating antibodies

Human herpesvirus trimeric glycoprotein B, protein complexes comprising trimeric gB and their use as vaccines

Vaccine against Lawsonia intracellularis and porcine circovirus 2

Immunogenic compositions and vaccines derived from bacterial surface receptor proteins

immunogenic vaccine compositions

Integration of meningococcal conjugate vaccination

Process for detergent-free production of outer membrane vesicles of a gram-negative bacterium

Composition for treating prostate cancer (PCa)

Fish vaccine

Fish vaccine

Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica

Method of treatment

Nucleic acids for treatment of allergies

Subunit vaccine platform based on multimeric ribonucleoproteins comprising nucleoproteins of a non-segmented negative-strand RNA virus as carriers of heterologous polypeptides

Tetanus toxoid and CCL3 improve DC vaccines

Tissue targeted antigenic activation of the immune response to treat cancers

Mycobacterial antigen composition

Bivalent swine influenza virus vaccine

Fusion proteins and combination vaccines comprising Protein E and Pilin A

Polyvalent conjugate vaccine for cancer

Vaccine comprising capsular polysaccharide conjugates

Mixed allergen compositions and methods for using the same

Stabilized human immunodeficiency virus (HIV) clade C envelope (Env) trimer vaccines and methods of using same

Attenuated strains

Influenza vaccines with reduced amounts of squalene

Chimeric Factor H Binding Proteins (fHBP) and Methods of Use

Process for stabilizing an adjuvant containing vaccine composition

Chimeric OspA genes, proteins and methods of use thereof

Vectors for expression of prostate-associated antigens

Peptide compositions having 4 linked CTL epitopes and uses thereof

Influenza virus mutants and uses therefor

Influenza virus mutants and uses therefor

Method of obtaining thermostable dried vaccine formulations

Recombinant Marek's disease viruses and uses thereof

Use of the SPP type III secretion proteins as a protective vaccination

Thermally stable vaccine formulations and microneedles

Arabinogalactan for enhancing the adaptive immune response

Bacterial vaccine and methods for manufacture thereof

Method for preparing virosomes

Attenuated mannheimia haemolytica vaccines and methods of making and use

Recombinant polypeptide construct comprising multiple enterotoxigenic fimbrial subunits

Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof

Swine dysentery vaccine

Combination neisserial compositions

Tumor antigens for determining cancer therapy

Vaccines for serogroup X meningococcus

proteins and nucleic acids

DIVALENT VACCINE COMPOSITIONS AND THE USE THEREOF FOR TREATING TUMORS

Process for preparing pneumococcal polysaccharide-protein conjugates

Methods And Compositions of Protein Antigens For The Diagnosis And Treatment of Herpes Simplex Viruses Type 1 And 2

Universal influenza vaccine

METHOD FOR PREPARING VIROSOMES

Dengue virus vaccine compositions and methods of use thereof

Combination neisserial compositions

Composition and uses thereof

Recombinant fusion antigen gene, recombinant fusion antigen protein and subunit vaccine composition having the same against infection of porcine reproductive and respiratory syndrome virus

Compositions and methods for administration of vaccines against dengue virus

Methods of inducing an immune response against HIV-1 using recombinant envelopes with improved coverage

Compositions comprising iscom particles and live micro-organisms

Aluminum compounds for use in therapeutics and vaccines

Methods for treating brain cancer using il-13r alpha 2 peptide-based compositions

Vaccines against hepatitis B virus

Application of mRNA for use as a therapeutic against tumour diseases

Application of mRNA for use as a therapeutic against tumor diseases

Application of mRNA for use as a therapeutic against tumour diseases

Application of mRNA for use as a therapeutic against tumour diseases

Vaccines and methods to treat lyme disease in dogs

NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS

Vaccine for PCV2 and mycoplasma

Vaccine to prevent mycoplasmal infections in waterfowl

Application of mRNA for use as a therapeutic against tumour diseases

Nanoemulsion influenza vaccine

Recombinant subunit dengue virus vaccine

Recombinant baculovirus vector and uses thereof

Method for improving the efficacy of a survivin vaccine in the treatment of cancer

Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteins

Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome

Vaccine against Rhipicephalus ticks

Compositions and methods for the treatment or prevention of human immunodeficiency virus infection

Alkylated influenza vaccines

Vaccines for human papilloma virus and methods for using the same

Vaccines for the prevention of infections with

MSI-specific frameshift peptides (FSP) for prevention and treatment of cancer

Immunogenic compositions for inducing an immune response for elimination of senescent cells

Bovine virus vaccines that are liquid stable

Single high dose of MVA induces a protective immune response in neonates and infants

OUTER MEMBRANE VESICLE (OMV) VACCINE COMPRISING N. MENINGITIDIS SEROGROUP B OUTER MEMBRANE PROTEINS

Influenza nucleic acid molecules and vaccines made therefrom

Rapid and prolonged immunologic-therapeutic

Peptide having 5 linked CTL epitopes

Vaccine combinations

Compositions and methods to treat AIDS

Recombinant gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof

Conditionally replication deficient herpes virus and use thereof in vaccines

Functional influenza virus-like particles (VLPS)

Norovirus vaccine formulations

CROSS-PROTECTION OF BOVINES AGAINST B. trehalosi INFECTION BY A MULTI-VALENT VACCINE

HER-1, HER-3 and IGF-1R compositions and uses thereof

Multivalent meningococcal polysaccharide-protein conjugate vaccine

Parenteral norovirus vaccine formulations

Polyvalent fusion protein vaccine against influenza

Functional influenza virus like particles (VLPs)

USE OF REPLICATION DEFICIENT HSV-1 AS A VACCINE VECTOR FOR THE DELI VARY OF HIV-1 TAT ANTIGEN

Vaccine comprising an oil in water emulsion

Synthetic Peptides as Carriers for Conjugation with Polysaccharides

Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens

MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION

Tissue targeted antigenic activation of the immune response to treat cancers

Subunit immersion vaccines for fish

Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy

Immunogenic Composition and Methods of Using the Compositions for Inducing Humoral and Cellular Immune Responses

Influenza virus vaccines and uses thereof

Compositions, methods of administration and uses for trivalent dengue virus formulations

Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

Vaccine for intrauterine disease

Dose selection of adjuvanted synthetic nanocarriers

Recombinant spike protein subunit based vaccine for porcine epidemic diarrhea virus (PEDV)

Dengue virus vaccine composition

Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions

Glycoconjugate vaccines

antigens and antigen combinations

Effective method of treatment of porcine circovirus and infections

Pneumococcal vaccine containing pneumococcal surface protein A

Vaccine for protection against ETEC-induced diarrhea comprising dmLT

Immune modulator for immunotherapy and vaccine formulation

Clostridium difficile polypeptides as vaccine

Influenza viruses with mutant PB2 segment as live attenuated vaccines

Vaccine and methods for detecting and preventing filariasis

Synthetic peptide-based emergency vaccine against foot and mouth disease (FMD)

Polypeptide vaccine

Influenza vaccination

Multivalent PCV2 immunogenic compositions and methods of producing such compositions

Multivalent PCV2 immunogenic compositions and methods of producing such compositions

Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida

Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response

PCV/mycoplasma hyopneumoniae/PRRS combination vaccine

vaccine

Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof

Influenza vaccines

PCV/combination vaccine

Human herpesvirus immunotherapy

Universal influenza vaccine based on heterologous multiple M2E proteins

VACCINE

NON-CROSS-LINKED ACELLULAR PERTUSSIS ANTIGENS FOR USE IN COMBINATION VACCINES

Pneumoccal polysacchride conjugate vaccine

Immunomodulating compositions and uses therefor

Mosaic clade M human immunodeficiency virus type 1 (HIV-1) gag immunogens

Recombinant novirhabdovirus usable as an antigen vector

VACCINE COMPOSITIONS FOR PREVENTION AGAINST DENGUE VIRUS INFECTION

VACCINES AND METHODS FOR CREATING A VACCINE FOR INDUCING IMMUNITY TO ALL DENGUE VIRUS SEROTYPES

INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES

HPV/CyaA-based chimeric proteins and their uses in the induction of immune responses against HPV infection and HPV-induced disorders

Bacterial composition for the treatment of colibacillosis on farms, in particular poultry farms, and also drinking water containing such a bacterial composition

Liquid stable virus vaccines

Live attenuated Shigella vaccine

Recombinant measles virus expressing chikungunya virus polypeptides and their applications

Multifunctional oral vaccine based on chromosome recombineering

Polysaccharide and uses thereof

WT1 antigen peptide conjugate vaccine

Compositions and methods related to diseases associated with deposits of amyloid, tau, and alpha-synuclein

Multivalent pneumococcal polysaccharide-protein conjugate composition

COMPOSITIONS AND METHODS FOR GENERATING AN IMMUNE RESPONSE

Immunogenic composition

Immunogenic compositions

IC31 nanoparticles

MVA vaccine for delivery of a UL128 complex and preventing CMV infection

Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof

Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment

LY6K epitope peptides for TH1 cells and vaccines containing the same

Polypeptides and immunizing compositions containing polypeptides and methods of use

Compositions and methods for the treatment or prevention of hepatitis B virus infection

Pneumococcal capsular saccharide conjugate vaccine

Polyvalent pneumococcal polysaccharide-protein conjugate composition

fHbp variant and its use for vaccination

CDCA1 epitope peptides for Th1 cells and vaccines containing the same

KIF20A epitope peptides for TH1 cells and vaccines containing the same

Methods of vaccine administration

Meningococcal And Pneumococcal Conjugate Vaccine And Method Of Using Same

COMPOSITIONS AND METHODS FOR TREATING AN ACTIVE MYCOBACTERIUM TUBERCULOSIS INFECTION

Fusion proteins and combination vaccines comprising Protein E and Pilin A

Multimeric fusion protein vaccine and immunotherapeutic

PCV2 immunogenic compositions and methods of producing such compositions

Detoxified endotoxin immunogenic compositions and uses thereof

OMPA and ASP14 in vaccine compositions and as diagnostic targets

Fusion proteins and combination vaccines comprising Protein E and Pilin A

Compositions and methods for rapid immunization against dengue virus

Method of producing a designer blood product, method of using a designer blood product, and diet for selectively enhancing blood profile

toxoid vaccine

Antigens and vaccines directed against human enteroviruses

Fish vaccine

Clostridium difficile toxin-based vaccine

Attenuated vaccines and methods of making and use thereof

Immunogenic Composition

Modular nanodevices for smart adaptable vaccines

IgE CH3 peptide vaccine

Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species

Epitope focusing by variable effective antigen surface concentration

Compositions and methods

Multivalent meningococcal conjugates and methods for preparing conjugates

Yeast-based therapeutic for chronic hepatitis B infection

FUSION PROTEINS AND METHODS OF USE

ANTIBODY PRODUCTION METHODS

vaccine serovar type four

Immunogenic compositions comprising FIV and HIV gag antigens

Recombinant polypeptide construct comprising multiple enterotoxigenic fimbrial subunits

LPS vaccine

ACELLULAR PERTUSSIS VACCINE

MULTI-SPECIFIC BINDING AGENTS

Use of TNFα inhibitor for treatment of psoriatic arthritis

Vaccine

Human respiratory syncytial virus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

compositions and methods thereof

Combined measles-malaria vaccine

Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein

PROCESS FOR THE PREPARATION AND USE OF A BIVALENT VACCINE AGAINST MORPHINE-HEROIN ADDICTION

Polyvalent chimeric OSPC vaccinogen and diagnostic antigen

Enhancing immunity to tuberculosis

Sequential and repeated immunization with four or more vector-based HIV gene vaccines

Equine encephalitis virus vaccines and methods of using thereof

Bacterial vaccine

Methods for detection of anti-cytomegalovirus neutralizing antibodies

Immunogenic composition

Polyanionic polymer adjuvants for Haemophilus influenzae B saccharide vaccines

Methods and Compositions Of Protein Antigens For The Diagnosis And Treatment of Herpes Simplex Viruses Type 1 and 2

Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene

Immunogenic compositions and methods

Alphavirus vectors for respiratory pathogen vaccines

Multivalent vaccine protection from infection

Compositions, methods and therapies for administering antigen peptide

Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity

Recombinant VapA and VapC peptides and uses thereof

Liquid vaccines for multiple meningococcal serogroups

Immunogenic composition

Tuberculosis compositions and methods of using the same

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

Method for formulating a vaccine containing at least two antigens capable of adsorbing onto aluminium oxyhydroxide

Multi-strain-reactive antibodies for therapy and diagnosis of influenza

Adjuvanted influenza virus compositions

MYCOBACTERIAL VACCINE VECTORS AND METHODS OF USING THE SAME

Anti-CD40 antibodies and methods of treating cancer

Method to enhance an immune response of nucleic acid vaccination

GP120 immunogens and methods inducing neutralizing antibodies to human immunodeficiency virus

Immunogenic compositions comprising

Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients

Synthetic peptide-based marker vaccine and diagnostic system for effective control of porcine reproductive and respiratory syndrome (PRRS)

West Nile Virus vaccine

Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals

ORF2 PROTEIN OF PCV2 SUBTYPE A (PCV2A) FOR USE IN CROSS-PROTECTION

Recombinant poxvirus vector comprising tetanus toxin fragment C

Fusion proteins representing different allergens and a vaccine against allergy to mites

IPNV-ISAV bivalent vaccine using a virus-like particle-based platform and methods of using the same

Multivalent pneumococcal polysaccharide-protein conjugate composition

Immunogenic complexes of polyanionic carbomers and Env polypeptides and methods of manufacture and use thereof

Compositions and methods for treatment of cytomegalovirus

Compositions and methods for dengue virus chimeric constructs in vaccines

MANUFACTURE OF VACCINES THAT CONTAIN BOTH HEPATITIS B VIRUS SURFACE ANTIGEN AND SURFACTANT

Use of GK-1 peptide expressed on M13 filamentous phage as pharmaceutical ingredient to enhance the efficiency of the immune response induced by vaccine or pathogen antigens

Influenza hemagglutinin protein-based vaccines

VACCINE COMPOSITION

Recombinant nonpathogenic MDV vector providing multivalent immunity

Hypoallergenic variants of mal d 1, the major allergen from malus domestica

Truncated L1 protein of human papillomavirus type 6

Norovirus vaccine formulations

Immune methods against influenza viruses and combinatorial vaccines thereof

Liquid stable bovine virus vaccines

Bovine virus vaccines that are liquid stable

Recombinant proteins and their therapeutic uses

Programming of cells for tolerogenic therapies

Vaccine composition with aluminium hydroxide nanoparticles

Hypo- and hyper-acetylated meningococcal capsular saccharides

Use of TNF alpha inhibitor for treatment of erosive polyarthritis

Immunogenic combination compositions and uses thereof

Group A streptococcal M-related proteins and methods of use

Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines

Immunization compositions and methods

Multivalent vaccines for rabies virus and filoviruses

Functional influenza virus-like particles (VLPs)

Immunogenic composition comprising mycoplasma antigens

Attenuated mannheimia haemolytica vaccines and methods of making and use

Recombinant influenza viruses and constructs and uses thereof

Process for stabilizing an adjuvant containing vaccine composition

Multiple antigen presenting immunogenic composition, and methods and uses thereof

Methods and compositions for inhibiting polyomavirus-associated pathology

Identification of a west nile virus CD4 T cell epitope and use thereof

Process for detergent-free production of outer membrane vesicles of a gram-negative bacterium

Recombinant low virulence bovine herpesvirus-1 (BoHV-1) vaccine vectors

Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof

HLA-A2 tumor associated antigen peptides and compositions

Pathogenic bacteria

Compositions, methods and uses for dengue virus serotype-4 constructs

Compositions and methods for vaccinating cattle

Influenza virus mutants and uses therefor

Inactivated chikungunya viruses (CHIKV) comprising an E1-K211E mutation

Vaccine

Immunogenic composition

Combined vaccines for prevention of porcine virus infections

Protein matrix vaccine compositions including polycations

Compositions for canine respiratory disease complex

Nucleic acids containing a synthetic codon-optimized Sin Nombre virus full-length M gene